Committed to Health Equity for All, BioNJ’s Health Equity in Clinical Trials Initiative will define concrete issues, identify long-term interventions, support companies to improve equity and access in their clinical trials strategies, benchmark best practices and shape policy.
Sign up to receive BioNJ’s bi-weekly e-newsletter, The BioLines Weekender, featuring the most up-to-date R&D news happening in New Jersey.
By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact